HOME >> BIOLOGY >> NEWS
Eastern Europe urged to prepare now for growing threat of HIV resistance

Eastern Europe is warned to prepare for HIV drug resistance, a problem that is now being witnessed in patients in Poland after only five years of HIV treatment being available. Experts at an HIV congress in Warsaw heard today that FUZEON (enfuvirtide, formerly known as T-20), the latest weapon in the fight against HIV drug resistance, is a valuable tool to both patients and payers in the treatment of HIV, particularly when used earlier in pre-treated patients.

Eastern Europe urged to prepare for HIV resistance

John Bowis, OBE, Member of the European Parliament applauds the Ministry of Health in Poland for taking a pro-active lead in the fight against HIV and drug resistance: "The growing problem of HIV resistance is a serious issue which all members of the EU have a responsibility to manage. We must commit to share knowledge, particularly those countries more experienced in tackling the HIV epidemic, in an effort to provide a consistent standard of care and avert a potential healthcare crisis. We need to ensure that all European countries are benefiting from new treatments and are allocating vital resources where they will be of most value."

The increasing prevalence of HIV drug resistance means that many patients can no longer benefit from the first three classes of HIV drugs. Unlike existing anti-HIV drugs, which act inside the cell once it has been infected, FUZEON works on the outside actively blocking the fusion of the virus with cells of the human immune system (CD4 cells). Because of this very different mechanism of action, FUZEON is active against HIV strains that have become resistant to current therapies. FUZEON reduces HIV levels and increases CD4 cell counts even in patients with resistance to the three conventional classes of HIV drugs.

Improving survival in pre-treated patients carrying drug-resistant HIV

Reduction in HIV levels and improvements in CD4 cell counts have been shown to result in improved s
'"/>

Contact: Alexander Watson
Alexander.watson@ketchum.com
44-771-267-5990
Ketchum
27-Oct-2003


Page: 1 2 3

Related biology news :

1. Eastern lowland gorilla population plummets 70 percent since 1994
2. Eastern U.S. benefits from emissions trading by power plants
3. Environment in Eastern Europe benefits from Swedish funding
4. USGS Finds That Mysterious Arkansas Bald Eagle Disease Has Spread To Ducks In Eastern States
5. Clean Air Act Reduces Acid Rain In Eastern U.S.
6. Even Moderate Air Pollution Reaching Eastern Wilderness Decreases Mountain Hikers Lung Function
7. European common frog found to use novel mating strategy
8. Zoonotic diseases - European scientists unite to fight diseases
9. Second call for proposals for the European Young Investigator Award
10. Common call for action on European Research Council (ERC)
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
(Date:3/21/2016)... , March 22, 2016 ... recognition with passcodes for superior security   ... a leading provider of secure digital communications services, today ... biometric technology and offer enterprise customers, particularly those in ... facial recognition and voice authentication within a mobile app, ...
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
Breaking Biology News(10 mins):
(Date:5/25/2016)... , ... May 25, 2016 , ... Scientists at the ... options being tried for mesothelioma may be hampering the research that could lead to ... Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... and Drug Administration (FDA) has granted the company’s orphan drug designation request covering ... orphan drug designation granted by the FDA. , Spinocerebellar ataxia is a ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Last week, Callan ... corporate executives and entrepreneurs, held The Future of San Diego Life Science event at ... Diego life science community attended the event with speakers Dr. Rich Heyman, former CEO ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media has released its ... Beyond. The paper outlines the key trends that are creating both opportunities and ... a lot of highs and lows as the precision agriculture market has grown ...
Breaking Biology Technology:
Cached News: